Notice - Public Comment Period Extension for the Final Supplementary Risk Assessment for the Boston University (BU) National Emerging Infectious Diseases Laboratories (NEIDL)

Download as PDF

Loading PDF...

43094 Federal Register / Vol. 77, No. 141 / Monday, July 23, 2012 / Notices public conduct during advisory committee meetings. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). Dated: July 17, 2012. Jill Hartzler Warner, Acting Associate Commissioner for Special Medical Programs. [FR Doc. 2012?17881 Filed 7?20?12; 8:45 am] BILLING CODE 4160?01?P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Advisory Committee on Organ Transplantation; Notice of Meeting mstockstill on DSK4VPTVN1PROD with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92?463), notice is hereby given of the following meeting: Name: Advisory Committee on Organ Transplantation (ACOT). Date and Time: August 28, 2012, 8:00 a.m. to 4:30 p.m. Eastern Daylight Time. Place: Rockville Hilton Hotel, 1750 Rockville Pike, Rockville, MD 20852. Status: The meeting will be open to the public. Purpose: Under the authority of 42 U.S.C. 217a, Section 222 of the Public Health Service Act, as amended, and 42 CFR 121.12 (2000), ACOT was established to assist the Secretary in enhancing organ donation, ensuring that the system of organ transplantation is grounded in the best available medical science, and assuring the public that the system is as effective and equitable as possible, and, thereby, increasing public confidence in the integrity and effectiveness of the transplantation system. ACOT is composed of up to 25 members, including the Chair. Members are serving as Special Government Employees and have diverse backgrounds in fields such as organ donation, health care public policy, transplantation medicine and surgery, critical care medicine and other medical specialties involved in the identification and referral of donors, non-physician transplant professions, nursing, epidemiology, immunology, law and bioethics, behavioral sciences, economics and statistics, as well as representatives of transplant candidates, transplant recipients, organ donors, and family members. Agenda: The Committee will hear reports including those from the three ACOT Work Groups: Declining Rates of Donation/ Geographical and Other Variations in Organ Distribution, Alignment of CMS Regulatory Requirements with OPTN and HRSA, and Brain Death Determination. Agenda items are subject to change as priorities indicate. After Committee discussion, members of the public will have an opportunity to comment. Because of the Committee?s full agenda and timeframe in which to cover the VerDate Mar2010 19:21 Jul 20, 2012 Jkt 226001 agenda topics, public comment will be limited. All public comments will be included in the record of the ACOT meeting. Meeting summary notes will be posted on the Department?s donation Web site at http://www.organdonor.gov/legislation/ advisory.html#meetings. The draft meeting agenda will be posted on https://www.team-psa.com/ACOT/ Summer2012/. In order to register for this meeting, please visit the Meeting Registration Page. The deadline to register is August 13, 2012. For all logistical questions and concerns, please contact Brittany Carey of PSA at 703?889?9033 or bcarey@explorepsa.com. Public Comment: Persons interested in providing an oral presentation should submit a written request, along with a copy of their presentation to: Passy Tongele, DoT, Healthcare Systems Bureau (HSB), Health Resources and Services Administration (HRSA), Room 12C?06, 5600 Fishers Lane, Rockville, Maryland 20857 or email at ptongele@hrsa.gov. Requests should contain the name, address, telephone number, email address, and any business or professional affiliation of the person desiring to make an oral presentation. Groups having similar interests are requested to combine their comments and present them through a single representative. The allocation of time may be adjusted to accommodate the level of expressed interest. Persons who do not file an advance request for a presentation, but desire to make an oral statement, may request it at the time of the public comment period. Public participation and ability to comment will be limited to space and time as it permits. For Further Information Contact: Patricia Stroup, Executive Secretary, ACOT, Healthcare Systems Bureau, Health Resources and Services Administration, 5600 Fishers Lane, Room 12C?06, Rockville, Maryland 20857; telephone (301) 443?1127. Dated: July 13, 2012. Jennifer Riggle, Deputy Director, Office of Management. [FR Doc. 2012?17830 Filed 7?20?12; 8:45 am] BILLING CODE 4165?15?P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Public Comment Period Extension for the Final Supplementary Risk Assessment for the Boston University (BU) National Emerging Infectious Diseases Laboratories (NEIDL) A Notice of Availability for the Final Supplementary Risk Assessment for the Boston University (BU) National Emerging Infectious Diseases Laboratories (NEIDL) was published in the Federal Register on July 6, 2012. Upon the publication of the Notice of Availability, a required comment period of at least 30 day began in which the National Institutes of SUMMARY: PO 00000 Frm 00050 Fmt 4703 Sfmt 9990 Health would accept and consider comments from the public on the final supplementary risk assessment. This comment period was set to end on August, 6, 2012. In order to provide the public with additional time to review and comment on the final supplementary risk assessment, the National Institutes of Health (NIH) has decided to extend the public comment period for the final supplementary risk assessment until August 24, 2012. Written comments on the final supplementary risk assessment must be postmarked no later than August 24, 2012. Comments should be sent to The National Institutes of Health, Office of Biotechnology Activities, Attn: NEIDL Risk Assessment, 6705 Rockledge Drive, Suite 750, Bethesda, Maryland, 20892. Email comments should be sent to NIH_BRP@od.nih.gov. Please note that comments sent by email must be received by 11:59 p.m. on the last day of the comment period, August 24, 2012. ADDRESSES: FOR FURTHER INFORMATION CONTACT: National Institutes of Health Office of Biotechnology Activities, 6705 Rockledge Drive, Suite 750, Bethesda, Maryland, 20892. Telephone number: (301) 496?9838. Electronic mail address: NIH_BRP@od.nih.gov. Availabilty of Copies and Electronic Access: Copies of the Final Supplementary Risk Assessment for the Boston University National Emerging Infectious Diseases Laboratory and the accompanying reader?s guide may be obtained at no cost by calling (301) 496? 9838, or by emailing requests to NIH_BRP@od.nih.gov. The documents are also available electronically at: http://nihblueribbonpanel-bumcneidl.od.nih.gov/default.asp. A copy of the final supplementary risk assessment and the reader?s guide has also been made available for review at each of the following locations: Central Branch of the Boston Public Library, 700 Boylston Street, Boston, MA; South End Library, 685 Tremont Street, Boston, MA; Grove Hall Library, 42 Geneva Avenue; and Dudley Library, 65 Warren Street, Boston, MA. Dated: July 18, 2012. Ryan T. Bayha, Science Policy Analyst, Office of Science Policy, National Institutes of Health. [FR Doc. 2012?18026 Filed 7?20?12; 8:45 am] BILLING CODE 4140?01?P E:\FR\FM\23JYN1.SGM 23JYN1

[Federal Register Volume 77, Number 141 (Monday, July 23, 2012)] [Notices] [Page 43094] From the Federal Register Online via the Government Printing Office [www.gpo.gov] [FR Doc No: 2012-18026]   -----------------------------------------------------------------------  DEPARTMENT OF HEALTH AND HUMAN SERVICES  National Institutes of Health   Public Comment Period Extension for the Final Supplementary Risk  Assessment for the Boston University (BU) National Emerging Infectious  Diseases Laboratories (NEIDL)  SUMMARY: A Notice of Availability for the Final Supplementary Risk  Assessment for the Boston University (BU) National Emerging Infectious  Diseases Laboratories (NEIDL) was published in the Federal Register on  July 6, 2012. Upon the publication of the Notice of Availability, a  required comment period of at least 30 day began in which the National  Institutes of Health would accept and consider comments from the public  on the final supplementary risk assessment. This comment period was set  to end on August, 6, 2012. In order to provide the public with  additional time to review and comment on the final supplementary risk  assessment, the National Institutes of Health (NIH) has decided to  extend the public comment period for the final supplementary risk  assessment until August 24, 2012.  ADDRESSES: Written comments on the final supplementary risk assessment  must be postmarked no later than August 24, 2012. Comments should be  sent to The National Institutes of Health, Office of Biotechnology  Activities, Attn: NEIDL Risk Assessment, 6705 Rockledge Drive, Suite  750, Bethesda, Maryland, 20892. Email comments should be sent to NIH_BRP@od.nih.gov. Please note that comments sent by email must be  received by 11:59 p.m. on the last day of the comment period, August  24, 2012.  FOR FURTHER INFORMATION CONTACT: National Institutes of Health Office  of Biotechnology Activities, 6705 Rockledge Drive, Suite 750, Bethesda,  Maryland, 20892. Telephone number: (301) 496-9838. Electronic mail  address: NIH_BRP@od.nih.gov.     Availabilty of Copies and Electronic Access: Copies of the Final  Supplementary Risk Assessment for the Boston University National  Emerging Infectious Diseases Laboratory and the accompanying reader's  guide may be obtained at no cost by calling (301) 496-9838, or by  emailing requests to NIH_BRP@od.nih.gov. The documents are also  available electronically at: http://nihblueribbonpanel-bumc-neidl.od.nih.gov/default.asp.     A copy of the final supplementary risk assessment and the reader's  guide has also been made available for review at each of the following  locations: Central Branch of the Boston Public Library, 700 Boylston  Street, Boston, MA; South End Library, 685 Tremont Street, Boston, MA;  Grove Hall Library, 42 Geneva Avenue; and Dudley Library, 65 Warren  Street, Boston, MA.      Dated: July 18, 2012. Ryan T. Bayha, Science Policy Analyst, Office of Science Policy, National Institutes  of Health. [FR Doc. 2012-18026 Filed 7-20-12; 8:45 am] BILLING CODE 4140-01-P

Source: http://regulations.justia.com/regulations/fedreg/2012/07/23/2012-18026.html

walking dead season finale matt flynn denver news frozen planet creighton new smyrna beach st. joseph